2015
DOI: 10.3892/mmr.2015.3787
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of FHL1 inhibits cigarette smoke extract-induced proliferation in pulmonary arterial smooth muscle cells

Abstract: Cigarette smoke can induce pulmonary vascular remodeling, which involves pulmonary artery smooth muscle cell (PASMC) proliferation, resulting in pulmonary hypertension in chronic obstructive pulmonary disease. FHL1 is a member of the FHL subfamily, characterized by an N‑terminal half LIM domain, followed by four complete LIM domains, and has been suggested to be critical in cell proliferation. However, the effects of FHL1 on cigarette smoke‑induced PASMC proliferation and the precise molecular mechanism remain… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
5
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 46 publications
3
5
0
Order By: Relevance
“…Thus, FHL1 may have exerted similar effect in the current HPH neonatal rat model. Additionally, the present data was consistent with previous findings that high expression of FHL1 was correlated with PASMC proliferation induced by cigarette smoke extract ( 29 ).…”
Section: Discussionsupporting
confidence: 93%
“…Thus, FHL1 may have exerted similar effect in the current HPH neonatal rat model. Additionally, the present data was consistent with previous findings that high expression of FHL1 was correlated with PASMC proliferation induced by cigarette smoke extract ( 29 ).…”
Section: Discussionsupporting
confidence: 93%
“…When ASMCs were transfected with calreticulin siRNA, the expression of calreticulin was significantly diminished at the mRNA level (P<0.05) and also suppressed at the protein level, compared with that in control siRNA-transfected ASMCs stimulated with 10% CSE. A previous study reported that calreticulin transcriptionally regulates C/EBP-α through a cis-regulatory CNG-rich loop in the mRNA of C/EBP-α (19). In the present study, knockdown of calreticulin resulted in an upregulation of the mRNA (P<0.05) and protein levels of C/EBP-α, and an increase in C/EBP-α expression in the nucleus in human ASMCs stimulated with 10% CSE (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…It has been suggested that inhibition of four and a half LIM domains protein 1 limited the CSE-induced proliferation of pulmonary arterial SMCs and may represent a potential therapeutic target for pulmonary hypertension (19). Furthermore, the results of the present study revealed that CSE promoted the proliferation of ASMCs via induction of calreticulin, which inhibits the expression of C/EBP-α.…”
Section: Discussionmentioning
confidence: 99%
“…FHL1 expression is also found significantly upregulated in pulmonary hypertension, particularly in the pulmonary vasculature 32. Furthermore, FHL1 has an important role in CSE-induced proliferation of pulmonary arterial smooth muscle cells and hypoxia-induced pulmonary hypertension 33,34. However, numerous studies implied that FHL1 may have a tumor suppressor activity and play significant roles in tumorigenesis and progression.…”
Section: Discussionmentioning
confidence: 99%